In the News

IV-WMS: Slow Adoption Remains A Threat to Compounding Safety
By Adam Leitenberger

Although the COVID-19 pandemic continues to strain budgets and resources, U.S. hospital pharmacies have made progress in adopting IV workflow management systems (IV-WMS)…

Go to the post »
Achieving Success With IV Room Verification Technology
By Karen Blum

From Specialty Pharmacy Continuum, November 15, 2024 Implementing IV workflow management system (IVWMS) technology is helpful for patient safety, but the planning can be challenging, one community hospital system discovered. One good place to start is to allow ample time for preparation before going live, said Allie Torrence, PharmD, BCPS, an assistant director at Methodist […]

Read More »
US Representative, Mike Kelly, introduces Safer Compounding in Hospitals Act
By

June 28, 2024 Press Release WASHINGTON, D.C. — This week, U.S. Rep. Mike Kelly (R-PA), a member of the Ways & Means Subcommittee on Health, introduced the Safer Compounding in Hospitals Act, legislation which would establish a budget-neutral program within Medicare to incentivize the preparation and compounding of intravenous (IV) drugs for Medicare beneficiaries in the inpatient hospital setting. […]

Read More »
IV Workflow Management Systems: A Century in the Making
By Tyler Nichols, PharmD, BCPS

The compounding of sterile medications for parenteral administration to patients is not a new process. Its history has involved numerous important transitions, many of which have been, unfortunately, sparked by errors and harm to patients. Most of the last century has been focused on the sterility and stability of these products, which ultimately led to […]

Read More »
Drug barcode guru and gadfly talks FDA rules and IV robotics
By Bill Siwicki

Patient safety advocate Mark Neuenschwander is now working to make hospital intravenous therapy as safe as humanly – and robotically – possible.

Read More »
Push Is On to Make IV-WMS Universal
By Gina Shaw

From Pharmacy Technology Report, March 12, 2020 In December 2014, a 65-year-old woman was at home in Bend, Ore., recovering from brain surgery she had recently undergone in Seattle. After experiencing bouts of anxiety, she went to the ER at a local hospital, where the doctor ordered IV administration of fosphenytoin, a low-risk antiseizure medication […]

Read More »
2019 and 2020: Optimistic? Pessimistic? It’s All Relative
By Marie Rosenthal and David Bronstein

That top level of quality is critical, especially in IV compounding, added Mark Neuenschwander, the founding director of THRIV, an organization advocating for accuracy in IV medication preparation.

Read More »